Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 7
2004 11
2005 22
2006 8
2007 7
2008 13
2009 16
2010 9
2011 16
2012 12
2013 5
2014 9
2015 8
2016 9
2017 12
2018 10
2019 10
2020 14
2021 19
2022 18
2023 14
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review.
Cortese S, Solmi M, Michelini G, Bellato A, Blanner C, Canozzi A, Eudave L, Farhat LC, Højlund M, Köhler-Forsberg O, Leffa DT, Rohde C, de Pablo GS, Vita G, Wesselhoeft R, Martin J, Baumeister S, Bozhilova NS, Carlisi CO, Leno VC, Floris DL, Holz NE, Kraaijenvanger EJ, Sacu S, Vainieri I, Ostuzzi G, Barbui C, Correll CU. Cortese S, et al. Among authors: sacu s. World Psychiatry. 2023 Feb;22(1):129-149. doi: 10.1002/wps.21037. World Psychiatry. 2023. PMID: 36640395 Free PMC article.
The Challenges of Treating Neovascular Age-Related Macular Degeneration.
Hollaus M, Bühl W, Schmidt-Erfurth U, Sacu S. Hollaus M, et al. Among authors: sacu s. Klin Monbl Augenheilkd. 2022 Aug;239(8):1033-1042. doi: 10.1055/a-1473-5713. Epub 2021 Jul 1. Klin Monbl Augenheilkd. 2022. PMID: 34198354 Free article. Review. English, German.
Retinal vein occlusions.
Buehl W, Sacu S, Schmidt-Erfurth U. Buehl W, et al. Among authors: sacu s. Dev Ophthalmol. 2010;46:54-72. doi: 10.1159/000320009. Epub 2010 Aug 10. Dev Ophthalmol. 2010. PMID: 20703032
Reply.
Sacu S, Rezar-Dreindl S. Sacu S, et al. Retina. 2017 Oct;37(10):e123. doi: 10.1097/IAE.0000000000001850. Retina. 2017. PMID: 28938296 No abstract available.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Feb 19:S0161-6420(24)00134-9. doi: 10.1016/j.ophtha.2024.02.014. Online ahead of print. Ophthalmology. 2024. PMID: 38382813 Free article.
Microvascular Retinal Changes in Patients with Marfan Syndrome.
Rezar-Dreindl S, Eibenberger K, Told R, Unterluggauer V, Sacu S, Schmidt-Erfurth U, Stifter E. Rezar-Dreindl S, et al. Among authors: sacu s. Curr Eye Res. 2022 Aug;47(8):1186-1192. doi: 10.1080/02713683.2022.2066698. Epub 2022 Apr 25. Curr Eye Res. 2022. PMID: 35416099
219 results